Monitoring Continuing Education in Long Trials
Monitoring Continuing Education in Long Trials Monitoring Continuing Education in Long Clinical Trials Introduction: Why Long Trials Need Enhanced Training Oversight Clinical trials often span several years—especially in oncology, neurology, and rare disease indications. During such extended timelines, site staff turnover, protocol amendments, and SOP changes make it essential to maintain ongoing training. Regulatory authorities…
Read More “Monitoring Continuing Education in Long Trials” »